Shares in Myomo fell yesterday after the wearable medical robotics company missed expectations on Wall Street with its first quarter earnings. The Cambridge, Mass.-based company posted losses of $2.3 million, or 20¢ per share, on sales of $313,179 for the three months ended March 31, seeing losses grow 50.7% while sales grew 44.8% compared with the […]
Myomo Inc
Myomo repays $1m MSLC accelerator loan
Myomo said this week it repaid a $750,000 accelerator loan from the Massachusetts Life Sciences Center it received in 2011. Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and hands to allow for functional […]
Myomo prices upcoming $10m offering
Myomo today priced an upcoming offering, looking to raise approximately $10 million to support its myoelectric braces and orthotics designed for individuals with neuromuscular disorders. In the offering, the Cambridge, Mass.-based company is looking to float approximately 4.2 million shares and warrants to purchase an additional 4.2 million shares at $2.40 per share. Warrants offered […]
Myomo readies $17m offering
Myomo said late last week it is looking to raise approximately $17.4 million in a new offering of shares and warrants to support its myoelectric braces and orthotics designed for individuals with neuromuscular disorders. In the offering the company plans to float approximately 1.5 million shares of common stock and warrants to purchase an additional […]
Myomo wins CE Mark for next-gen MyoPro powered orthotic
Myomo said today it won CE Mark approval in the European Union for its next-gen MyoPro myoelectric arm orthosis device. Cambridge, Mass.-based Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and hands to allow […]
Mediware taps ex-Optum exec Miller for CEO | Personnel Moves July 28, 2017
Healthcare tech group Mediware Information Systems said it tapped former United-Health Group subsidiary OptumInsight chief exec Bill Miller as its new CEO, replacing Kelly Mann, who has served in the corner office since 2007. Mediware said that Miller will work with the Lenexa, Kansas-based company’s management to “build and accelerate the company’s platform” to expand […]
Myomo touts reduced upper extremity impairment in MyoPro trial
Myomo yesterday released results from an investigator-led study of its MyoPro myoelectric orthotic, touting reduced upper extremity impairment with the use of the device. Cambridge, Mass.-based Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed […]
On the heels of its IPO, Myomo launches next-gen MyoPro 2 powered orthotic
Just after reeling in $5 million from its initial public offering, Myomo said today it is launching its next-generation MyoPro 2 myoelectric arm orthosis designed to restore function to paralyzed or weakened arms. The MyoPro 2 is designed to aid patients in performing daily living activities including eating, carrying objects and general household chores, as […]
Myomo closes $5m IPO
Myomo said last week it closed its initial public offering, raising $5 million and listing on the New York Stock Exchange today under the ticker “MYO”. The Cambridge, Mass.-based company develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak […]
Robotic arm brace maker Myomo looks for $15m in Regulation A+ IPO
Myomo said today it is looking to raise up to $15 million in a Regulation A+ initial public offering and gain listing on the New York Stock Exchange MKT. The Cambridge, Mass.-based company is taking advantage of new federal securities law under the Jumpstart Our Business Startups Act passed under Obama, which allow small private companies to […]
Myomo registers for IPO
Myomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE under the ticker symbol “MYO”. Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and […]